Friday, November 26, 2010

Combining NO release W/ anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a MPTP model of Parkinson's disease

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

No comments:

Post a Comment